Taken together, our results suggested that leptin is a potential therapeutic target for NPC and RNA-based strategies to target leptin are sufficient to reduce the effects of leptin on NPC carcinogenesis. The gene discussed is LEP; the disease is nasopharyngeal carcinoma.